Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1987 Mar;126(3):546–560.

Immunoreactivity for Leu-7 in neurofibrosarcoma and other spindle cell sarcomas of soft tissue.

P E Swanson, J C Manivel, M R Wick
PMCID: PMC1899642  PMID: 3103455

Abstract

Monoclonal antibodies to Leu-7 have been reported to recognize a constituent of myelin-associated glycoprotein. Because of this, the authors studied 20 cases of neurofibrosarcoma (NFS), 7 of leiomyosarcoma (LMS), 3 of fibrosarcoma (FS), 8 of malignant fibrous histiocytoma (MFH), 5 of monophasic spindle cell synovial sarcoma (MSS), 5 of neurilemmoma, and 5 of neurofibroma for Leu-7 reactivity, to determine its utility in differential diagnosis. Selected examples of each tumor type were also studied ultrastructurally. Leu-7 was compared with the expression of S-100 protein, myelin basic protein, desmin, cytokeratin, and epithelial membrane antigen in the 43 neoplasms. Fifteen examples of NFS, 2 of LMS, and 2 of MSS were Leu-7+; 2 neurofibromas and 4 neurilemmomas also demonstrated reactivity with this antibody. In contrast, all cases of FS and MFH were Leu-7-. Synovial sarcomas could be effectively separated from NFS by reactivities for cytokeratin and epithelial membrane antigen in the former, but not the latter, lesions. However, LMSs and NFSs demonstrated significant immunocytochemical overlap, including shared positivity for S-100, desmin, and myelin basic protein in several cases. These results suggest that Leu-7 has restricted utility in immunohistochemical diagnosis, and must be utilized only in concert with other antigens. Moreover, it would appear that in selected instances, smooth-muscle and neurogenic sarcomas must be separated on the basis of clinical, histopathologic, and ultrastructural features alone.

Full text

PDF
546

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Bunn P. A., Jr, Linnoila I., Minna J. D., Carney D., Gazdar A. F. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood. 1985 Mar;65(3):764–768. [PubMed] [Google Scholar]
  3. Clark H. B. Immunohistochemistry of nervous system antigens: diagnostic applications in surgical neuropathology. Semin Diagn Pathol. 1984 Nov;1(4):309–316. [PubMed] [Google Scholar]
  4. Clark H. B., Minesky J. J., Agrawal D., Agrawal H. C. Myelin basic protein and P2 protein are not immunohistochemical markers for Schwann cell neoplasms. A comparative study using antisera to S-100, P2, and myelin basic proteins. Am J Pathol. 1985 Oct;121(1):96–101. [PMC free article] [PubMed] [Google Scholar]
  5. D'AGOSTINO A. N., SOULE E. H., MILLER R. H. SARCOMAS OF THE PERIPHERAL NERVES AND SOMATIC SOFT TISSUES ASSOCIATED WITH MULTIPLE NEUROFIBROMATOSIS (VON RECKLINGHAUSEN'S DISEASE). Cancer. 1963 Aug;16:1015–1027. doi: 10.1002/1097-0142(196308)16:8<1015::aid-cncr2820160808>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  6. Daimaru Y., Hashimoto H., Enjoji M. Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases. Am J Surg Pathol. 1985 Jun;9(6):434–444. doi: 10.1097/00000478-198506000-00005. [DOI] [PubMed] [Google Scholar]
  7. Denk H., Krepler R., Artlieb U., Gabbiani G., Rungger-Brändle E., Leoncini P., Franke W. W. Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors. Am J Pathol. 1983 Feb;110(2):193–208. [PMC free article] [PubMed] [Google Scholar]
  8. Dobersen M. J., Gascon P., Trost S., Hammer J. A., Goodman S., Noronha A. B., O'Shannessy D. J., Brady R. O., Quarles R. H. Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood. Proc Natl Acad Sci U S A. 1985 Jan;82(2):552–555. doi: 10.1073/pnas.82.2.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erlandson R. A., Woodruff J. M. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer. 1982 Jan 15;49(2):273–287. doi: 10.1002/1097-0142(19820115)49:2<273::aid-cncr2820490213>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  10. Evans H. L. Synovial sarcoma. A study of 23 biphasic and 17 probable monophasic examples. Pathol Annu. 1980;15(Pt 2):309–331. [PubMed] [Google Scholar]
  11. Guccion J. G., Enzinger F. M. Malignant Schwannoma associated with von Recklinghausen's neurofibromatosis. Virchows Arch A Pathol Anat Histol. 1979 Jul 27;383(1):43–57. doi: 10.1007/BF00427009. [DOI] [PubMed] [Google Scholar]
  12. Heyderman E., Strudley I., Powell G., Richardson T. C., Cordell J. L., Mason D. Y. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer. 1985 Sep;52(3):355–361. doi: 10.1038/bjc.1985.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  14. Kahn H. J., Marks A., Thom H., Baumal R. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol. 1983 Mar;79(3):341–347. doi: 10.1093/ajcp/79.3.341. [DOI] [PubMed] [Google Scholar]
  15. Krall R. A., Kostianovsky M., Patchefsky A. S. Synovial sarcoma: a clinical, pathological, and ultrastructural study of 26 cases supporting the recognition of a monophasic variant. Am J Surg Pathol. 1981 Mar;5(2):137–151. [PubMed] [Google Scholar]
  16. Lipinski M., Braham K., Caillaud J. M., Carlu C., Tursz T. HNK-1 antibody detects an antigen expressed on neuroectodermal cells. J Exp Med. 1983 Nov 1;158(5):1775–1780. doi: 10.1084/jem.158.5.1775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mackay B., Osborne B. M. The contribution of electron microscopy to the diagnosis of tumors. Pathobiol Annu. 1978;8:359–405. [PubMed] [Google Scholar]
  18. Matsunou H., Shimoda T., Kakimoto S., Yamashita H., Ishikawa E., Mukai M. Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma). Cancer. 1985 Nov 1;56(9):2269–2279. doi: 10.1002/1097-0142(19851101)56:9<2269::aid-cncr2820560922>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  19. McGarry R. C., Helfand S. L., Quarles R. H., Roder J. C. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature. 1983 Nov 24;306(5941):376–378. doi: 10.1038/306376a0. [DOI] [PubMed] [Google Scholar]
  20. Miettinen M., Lehto V. P., Badley R. A., Virtanen I. Expression of intermediate filaments in soft-tissue sarcomas. Int J Cancer. 1982 Nov 15;30(5):541–546. doi: 10.1002/ijc.2910300502. [DOI] [PubMed] [Google Scholar]
  21. Miettinen M., Virtanen I. Synovial sarcoma--a misnomer. Am J Pathol. 1984 Oct;117(1):18–25. [PMC free article] [PubMed] [Google Scholar]
  22. Mogollon R., Penneys N., Albores-Saavedra J., Nadji M. Malignant schwannoma presenting as a skin mass. Confirmation by the demonstration of myelin basic protein within tumor cells. Cancer. 1984 Mar 1;53(5):1190–1193. doi: 10.1002/1097-0142(19840301)53:5<1190::aid-cncr2820530527>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  23. Morales A. R., Fine G., Pardo V., Horn R. C., Jr The ultrastructure of smooth muscle tumors with a consideration of the possible relationship of glomangiomas, hemangiopericytomas, and cardiac myxomas. Pathol Annu. 1975;10:65–92. [PubMed] [Google Scholar]
  24. Mukai M. Immunohistochemical localization of S-100 protein and peripheral nerve myelin proteins (P2 protein, P0 protein) in granular cell tumors. Am J Pathol. 1983 Aug;112(2):139–146. [PMC free article] [PubMed] [Google Scholar]
  25. Nakajima T., Watanabe S., Sato Y., Kameya T., Hirota T., Shimosato Y. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol. 1982 Dec;6(8):715–727. doi: 10.1097/00000478-198212000-00003. [DOI] [PubMed] [Google Scholar]
  26. Nobile-Orazio E., Hays A. P., Latov N., Perman G., Golier J., Shy M. E., Freddo L. Specificity of mouse and human monoclonal antibodies to myelin-associated glycoprotein. Neurology. 1984 Oct;34(10):1336–1342. doi: 10.1212/wnl.34.10.1336. [DOI] [PubMed] [Google Scholar]
  27. O'BRIEN J. E., STOUT A. P. MALIGNANT FIBROUS XANTHOMAS. Cancer. 1964 Nov;17:1445–1455. doi: 10.1002/1097-0142(196411)17:11<1445::aid-cncr2820171112>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  28. Penneys N. S., Adachi K., Ziegels-Weissman J., Nadji M. Granular cell tumors of the skin contain myelin basic protein. Arch Pathol Lab Med. 1983 Jun;107(6):302–303. [PubMed] [Google Scholar]
  29. Penneys N. S., Mogollon R., Kowalczyk A., Nadji M., Adachi K. A survey of cutaneous neural lesions for the presence of myelin basic protein. An immunohistochemical study. Arch Dermatol. 1984 Feb;120(2):210–213. [PubMed] [Google Scholar]
  30. Perentes E., Rubinstein L. J. Immunohistochemical recognition of human nerve sheath tumors by anti-Leu 7 (HNK-1) monoclonal antibody. Acta Neuropathol. 1985;68(4):319–324. doi: 10.1007/BF00690835. [DOI] [PubMed] [Google Scholar]
  31. Pinkus G. S., Kurtin P. J. Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol. 1985 Sep;16(9):929–940. doi: 10.1016/s0046-8177(85)80132-5. [DOI] [PubMed] [Google Scholar]
  32. Pritchard D. J., Soule E. H., Taylor W. F., Ivins J. C. Fibrosarcoma--a clinicopathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk. Cancer. 1974 Mar;33(3):888–897. doi: 10.1002/1097-0142(197403)33:3<888::aid-cncr2820330339>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  33. Salisbury J. R., Isaacson P. G. Synovial sarcoma: an immunohistochemical study. J Pathol. 1985 Sep;147(1):49–57. doi: 10.1002/path.1711470107. [DOI] [PubMed] [Google Scholar]
  34. Shmookler B. M., Lauer D. H. Retroperitoneal leiomyosarcoma. A clinicopathologic analysis of 36 cases. Am J Surg Pathol. 1983 Apr;7(3):269–280. [PubMed] [Google Scholar]
  35. Tsuneyoshi M., Enjoji M. Primary malignant peripheral nerve tumors (malignant schwannomas). A clinicopathologic and electron microscopic study. Acta Pathol Jpn. 1979 May;29(3):363–375. doi: 10.1111/j.1440-1827.1979.tb00194.x. [DOI] [PubMed] [Google Scholar]
  36. Vanstapel M. J., Gatter K. C., de Wolf-Peeters C., Mason D. Y., Desmet V. D. New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol. 1986 Feb;85(2):160–168. doi: 10.1093/ajcp/85.2.160. [DOI] [PubMed] [Google Scholar]
  37. Weidenheim K. M., Campbell W. G., Jr Perineural cell tumor. Immunocytochemical and ultrastructural characterization. Relationship to other peripheral nerve tumors with a review of the literature. Virchows Arch A Pathol Anat Histopathol. 1986;408(4):375–383. doi: 10.1007/BF00707695. [DOI] [PubMed] [Google Scholar]
  38. Weiss S. W., Enzinger F. M. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978 Jun;41(6):2250–2266. doi: 10.1002/1097-0142(197806)41:6<2250::aid-cncr2820410626>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  39. Weiss S. W., Langloss J. M., Enzinger F. M. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest. 1983 Sep;49(3):299–308. [PubMed] [Google Scholar]
  40. Wile A. G., Evans H. L., Romsdahl M. M. Leiomyosarcoma of soft tissue: a clinicopathologic study. Cancer. 1981 Aug 15;48(4):1022–1032. doi: 10.1002/1097-0142(19810815)48:4<1022::aid-cncr2820480429>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES